Newer diabetes medications that are injected once a week include Exenatide Microspheres for Injection.
Exenatide Microspheres for Injection can be used to improve glycemic control in patients with diabetes mellitus who continue to have poor glycemic control despite treatment with metformin, sulfonylurea, or metformin combined with a sulfonylurea glucose-lowering medication alone. It is contraindicated in people with medullary thyroid cancer, personal or family history of medullary thyroid cancer, people with multiple endocrine adenomatosis type 2, and people who are allergic to this drug.
This medication is generally recommended to be administered subcutaneously every seven days and can be given at any time of the day, on an empty stomach or with food; adverse reactions such as nausea, vomiting, diarrhea, and impaired renal function may occur after administration.
Patients who need to be treated with injectable exenatide microspheres should use the medication under the supervision of a doctor.